share_log

Stifel Maintains Hold on Deciphera Pharmaceuticals, Raises Price Target to $18

Stifel Maintains Hold on Deciphera Pharmaceuticals, Raises Price Target to $18

Stifel维持对Deciphera Pharmicals的控股,将目标股价提高至18美元
Benzinga Real-time News ·  2022/09/27 07:02

Stifel analyst Bradley Canino maintains Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Hold and raises the price target from $11 to $18.

Stifel分析师布拉德利·卡尼诺维持持有Deciphera Pharmicals(纳斯达克股票代码:DCPH),并将目标股价从11美元上调至18美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发